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a  b  s  t  r  a  c  t
Base  excision  repair (BER)  is believed  to be the  predominant  pathway  for the  repair  of oxidative  DNA
damage.  BER  is  initiated  by  lesion-speciﬁc  DNA  glycosylases  that  recognize  and  remove  the damaged
base.  NEIL1,  NEIL2  and  NEIL3  are  three  mammalian  members  of  the  Fpg/Nei  DNA  glycosylase  family  with
similar  enzymatic  properties.  In this  study  we  showed  that  both  the  transcription  and  protein  levels  of
hNEIL3  ﬂuctuated  during  the  cell cycle.  Based  on predicted  promoter  elements  of  cell cycle-regulated
genes  and  microarray  data  from  various  reports,  we  suggest  that  hNEIL3  repression  in quiescent  cells
might  be  mediated  by the  DREAM  (DP1,  RB  p130,  E2F4  and  MuvB  core  complex)  complex.  Release  fromNA  glycosylase
EIL3
ell  cycle regulation
AP  kinase
G0  by mitogenic  stimulation  showed  an induction  of hNEIL3  in  early  S phase  under  the control  of  the
Ras  dependent  ERK–MAP  kinase  pathway.  In contrast,  the  total  expression  of  hNEIL1  was  downregulated
upon  release  from  quiescence  while  the  expression  of  hNEIL2  was  cell  cycle  independent.  Notably,  hNEIL3
showed  a  similar  regulation  pattern  as  the  replication  protein  hFEN1  supporting  a function  of  hNEIL3  in
replication  associated  repair.  Thus,  it appears  that  specialized  functions  of the  NEILs  are  ensured  by their
expression  patterns.. Introduction
To preserve genetic information the DNA must be protected
rom damage generated spontaneously or induced by environ-
ental agents [1]. To counteract DNA damage, different repair
echanisms have evolved for the many types of DNA lesions.
NA glycosylases in the base excision repair (BER) pathway recog-
izes and excise speciﬁc base lesions leaving an abasic site [2–5].
epair synthesis is completed by several BER enzymes executing
ap ﬁlling and ligation [2]. DNA glycosylases that recognize oxi-
ized bases have been divided into two structural families, the Nth
amily and the Fpg/Nei family [6,7]. Three Fpg/Nei homologues des-
gnated hNEIL1, hNEIL2 and hNEIL3 in humans and mNeil1, mNeil2
nd mNeil3 in mouse respectively, have been identiﬁed in mam-
als [8–12]. These are bifunctional glycosylases, also cleaving the
xposed backbone at the abasic site. NEIL3 is the largest member
f the family, consisting N-terminally of the characteristic Fpg/Nei
otifs and C-terminally of a disordered extension with unique
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niversity Hospital, Rikshospitalet, PO Box 4950 Nydalen, NO-0424 Oslo, Norway.
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structural features containing a Ranbp-like zinc ﬁnger motif, a puta-
tive NLS and tandem repeated GRF zinc ﬁnger motifs.
NEIL1 and NEIL2 have been extensively studied biochemically.
In the case of NEIL3, only the mouse ortholog, mNeil3, has been
examined thoroughly [13]. In summary, the three homologues
have broad and overlapping speciﬁcity for oxidative lesions and
a preference for single stranded DNA, bubble and fork structures.
Hydantions such as spiroimidodihydantoin (Sp) and guanidino-
hydantoin (Gh) are the preferred substrates for mNeil3. These
lesions have garnered much attention due to their extremely high
mutagenic potential in cells which is signiﬁcantly greater than
8-oxoG [14]. Altogether, a function during replication or transcrip-
tion when partly unwound regions of DNA are exposed has been
suggested for the NEILs. All three proteins have been reported
to be localized in the nucleus, while hNEIL1 has been shown to
be found also in mitochondria [10,11,15,16]. Human NEIL1 and
hNEIL2 are ubiquitously expressed although at different levels in
distinct organs [9–11]. In contrast, hNEIL3 is expressed in thymus
and testis and in multiple forms of cancer, while mNeil3 is expressed
in hematopoietic tissue and testis, during embryonic development
and in stem/progenitor rich regions in the brain [11,16–20]. Thus,
Open access under CC BY-NC-ND license.hNEIL3/mNeil3 might function to remove lesions from the genome
in proliferating cells. During the cell cycle, the expression of hNEIL1
has been reported to be induced in S phase [9]. Functional interac-
tions of hNEIL1 with WRN, PCNA, FEN1 and RPA have suggested that
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Table 1
Primers used in Real-Time qRT-PCR.
Target Sequence (5′ → 3′) Acc. nr.
NEIL1 (+)-GCTGACCCTGAGCCAGAAGAT NM 024608.2
(−)-CCCCAACTGGACCACTTCCT
NEIL2 (+)-ACCTGTGACATCCTGTCTGAGAAGT NM 145043.2
(−)-TAATGATGTTCCCTAGCCCTGAGA
NEIL3 (+)-GGTCTCCACCCAGCTGTTAAAG NM 018248.2
(−)-CACGTATCATTTTCATGAGGTGATG
UNG2 (+)-GCCAGAAGACGCTCTACTCC NM 080911
(−)-GTGTCGCTTCCTGGCGGG
FEN1 (+)-AGGGAGAGCGAGCTTAGGAC NM 004111
(−)-GGCAACACAGAGGAGGGAT02 C.G. Neurauter et al. / D
NEIL1 is probably involved in repairing the replicating genome
21–25]. Unlike hNEIL1, hNEIL2 expression is independent of the
ell cycle stage and was recently shown to be involved in repairing
xidized bases in the transcribed genes of mammalian cells [10,26].
Transition through the mammalian cell cycle requires interplay
f transcription factors that together induce or repress gene expres-
ion in a temporally deﬁned manner. The E2Fs are a large family of
ranscription factors that bind target promoters and regulate their
xpression. There are eight known members of the E2F family in
ammals, and they form active DNA-binding heterodimers with
ither DP1 or DP2 [27–29]. E2F activity is controlled in part by
nteractions with members of the pRB (pocket protein) family: the
B tumor suppressor, p107 and p130 [30]. The DREAM (DP1, RB
130, E2F4, and MuvB core complex) complex represses cell cycle-
ependent genes during quiescence maintaining cells in G0 phase
31]. Upon re-entry into the cell cycle, the repressive complex is
elieved by CDKs (cyclin-dependent kinases) that phosphorylate RB
roteins in a cell cycle dependent manner [32,33]. The activation
f CDKs involves the mitogenic stimulation of receptor tyrosine
inases (RTKs) and the downstream mitogen activated protein
MAP) kinase pathways [34–36]. Activation complexes as E2F1-NF-
, E2F1-Sp1 can then be recruited to the promoter [37–39].
In  the present study we have examined the cell cycle-dependent
egulation of hNEIL3 at the transcriptional and protein level in com-
arison with other repair and replication associated genes and in
ells from different origins. Furthermore, we have identiﬁed several
utative cell cycle-regulated promoter elements and demonstrated
he involvement of the Ras dependent ERK–MAP kinase pathway
n the induction of hNEIL3 expression.
. Materials and methods
.1.  Cells
Human embryonic ﬁbroblasts (HE) were obtained from the
ational Institute of Public Health (Folkehelsa, Oslo, Norway).
RC-5 (human fetal lung primary ﬁbroblasts), HaCaT (human ker-
tinocytes) and MCF-7 (human epithelial breast cancer cell line)
ere obtained from ATCC. HE cells were cultured in a 1:1 ratio
inimal essential medium (MEM)  + Dulbecco’s modiﬁed Eagle’s
edium (DMEM) (Gibco, Life Technologies, Carlsbad, CA, USA)
atio supplemented with 10% fetal bovine serum (Standard qual-
ty FBS, PAA lab, GmbH, Austria), 1× GlutaMax (200 mM,  Gibco,
ife Technologies), and 1× penicillin–streptomycin (10,000 U/ml,
onza, Basel, Switzerland). MRC-5, HaCaT and MCF-7 cells were cul-
ured in DMEM supplemented with 10% FBS, 1× GlutaMax and 1×
en-Strep.
.2. Cell cycle synchronization and analysis by ﬂow cytometry
Synchronization of the cells in G0 phase was achieved by cultur-
ng cells as a conﬂuent layer for 72 h followed by serum starvation
0.2% serum) for 72 h. The cells were G0 released by trypsination for
 min  at 37 ◦C (Trypsin-EDTA (200 mg/L), Lonza) and cultivated in
tandard growth medium at 25% conﬂuence. Cells were harvested
y trypsination at indicated time points, washed in ice-cold PBS
nd stored at −20 ◦C. Cells used for phase analysis were resus-
ended in PBS and ﬁxed by addition of ice-cold 100% ethanol to
 ﬁnal concentration of 70%. The cells were stored at −20 ◦C. For
ACS analysis the cells (about 106/ml) were stained with propidium
odide (50 g/ml, Sigma–Aldrich, St. Louis, MO,  USA) in 0.1 mg/ml
NaseA (Molzym GmbH & Co, Bremen, Germany)/0.1% Triton X-
00 (Sigma–Aldrich)/4 mM Na-citrate buffer for 10 min  at 37 ◦C
nd put on ice. Cells were subjected to ﬂow cytometric analysis
BD LSRII ﬂow cytometer (Becton Dickinson, San Jose, CA, USA),GAPDH (+)-CCACATCGCTCAGACACCAT NM 002046.3
(−)-GCGCCCAATACGACCAAAT
and the results were analyzed with the CellQuest software (Becton
Dickinson).
2.3. Kinase and ROS inhibitor treatment of HE cells
Synchronized cells were trypsinized and resuspended in growth
medium without serum. The cells were preincubated with kinase
inhibitor for 15 min  and plated in complete growth medium
with addition of inhibitor at 25% conﬂuence. Inhibitors used:
SB203580 (p38a,b,b2 inhibitor, 10 M,  Promega Corp, Madison,
WI, USA), SP600125 (JNK inhibitor, 20 M,  Sigma–Aldrich), U0126
(MEK inhibitor, 20 M,  Promega) and N-acetyl cystein (NAC, ROS
inhibitor, 10 mM,  Sigma–Aldrich). Cells were harvested at indicated
time points as described.
2.4.  Total RNA isolation, cDNA synthesis and Real-Time qRT-PCR
Total  RNA was  extracted from cell pellets using the RNeasy kit
(QIAGEN GmbH, Hilden, Germany) according to protocol. The RNA
was treated with TurboDNase (Applied Biosystems, Foster City, CA,
USA) and the purity controlled by absorbance (260/280 nm and
260/230 nm)  measurements using Nanodrop spectrophotometer.
cDNA was synthesized from 50 ng RNA in 20 l reaction using the
High-Capacity cDNA Reverse Transcription kit (Applied Biosytems).
Real-Time qRT-PCR was performed in 20-l reactions containing
2.5 ng of cDNA and 100 nM primers using the Power SYBR Green
PCR master mix  and the Step One Plus Real-Time PCR system
(Applied Biosystems) according to the system and kit instructions.
The following thermal cycle parameters were used: 10 min at 95 ◦C,
40 cycles of 15 s at 95 ◦C and 1 min  at 60 ◦C. All samples were run
in triplicate. Melting point analyses were performed to conﬁrm the
speciﬁcity of the PCR. Relative quantitation (RQ) or fold change of
gene expression was calculated using the comparative CT method
described by the manufacture (Applied Biosystems) GAPDH was
used as the reference gene for normalization, G0 as the reference
sample for RQ calculation. Primers (Table 1) were designed using
the Primer Express software version 2.0 (Applied Biosystems).
2.5.  Immunoprecipitation and Western blotting
All procedures were performed at 4 ◦C. Cell pellets containing
about 107 cells collected at given time points were suspended in
1 ml  of lysis buffer (50 mM Tris–HCl pH 7.5, 500 mM NaCl, 1.0%
NP-40, 1% Protease Inhibitor Cocktail (P8340, Sigma–Aldrich)), and
disrupted by sonication. Cell lysates were centrifuged, and pro-
tein concentration was determined by the Bradford method using
the DC Protein Assay Kit II (Bio-Rad, Hercules, CA, USA). 1 mg  of
extract was  incubated with 10 g of normal rabbit IgG (sc-2027,
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anta Cruz Biotechnology, Santa Cruz, CA, USA) and 20 l Pro-
ein A/G PLUS Agarose (sc-2003, Santa Cruz Biotechnology). The
re-cleared extract was incubated with 1 g of NEIL3 PolyClonal
ntibody (11621-1-AP, ProteinTech Group, Chicago, IL, USA) and
0 l Protein A/G PLUS Agarose (sc-2003, Santa Cruz Biotechnol-
gy). The beads were washed four times and after the ﬁnal wash the
ample was divided into two tubes. The contents of one tube were
ubjected to Western blot analysis and the other to DNA glycosylase
ctivity.
Proteins were separated on 10% denaturing SDS-polyacrylamide
el (NuPage, Invitrogen Life Technologies, Carlsbad, CA, USA) and
ransferred to Hybond-P PVDF Membrane (Amersham Biosciences,
iscataway, NJ, USA). The membrane was incubated with the
rimary antibody NEIL3 PolyClonal Antibody (11621-1-AP, Pro-
einTech Group) at 4 ◦C overnight followed by incubation with
eroxidase-labeled goat polyclonal secondary antibody to rabbit
gG-H and L(HRP) (ab6721, Abcam, Cambridge, MA,  USA) for 1 h at
oom temperature. The membrane was treated with chemilumi-
escence reagent Immun-StarTM WesternCTM Chemiluminescence
it  (170-5070, Bio-Rad) and bands were visualized by ChemiDoc
RS system (Bio-Rad).
.6.  Gh assay for enzymatic cleavage of DNA.
The guanindinohydantoin (Gh) containing oligonucleotide
ubstrate was a kind gift from Prof. Cynthia J. Burrows, Depart-
ent of Chemistry, University of Utah. The oligonucleotide (5′
gttcatcatgcgtc Ghtcggtatatcccat 3′) containing a single Gh was
2P-endlabeled by T4 polynucleotide kinase (PNK) (New England
iolabs, Ipswich, MA,  USA) and [-32P]adenosine triphosphate
NEG502A, PerkinElmer, Waltham, MA,  USA) by incubation for
0 min  at 37 ◦C. PNK was deactivated at 80 ◦C. The labeled
ligonucleotide was puriﬁed by 20% native polyacrylamide gel elec-
rophoresis and visualized by storage phosphor autoradiography
Typhoon 9410 (Molecular Dynamics, Sunnyvale, CA, USA)). The
adiolabeled substrate was isolated from the gel, eluted in dH2O
nd stored at 4 ◦C. The incision assay was performed as previously
eported [11] with modiﬁcations. To immunoprecipitate samples,
0 fmol DNA substrate (32P-labeled oligomer), 100 ng ss competi-
or DNA (35-nucleotide random sequence), were mixed in reaction
uffer (50 mM MOPS pH 7.5, 1 mM EDTA, 5% glycerol and1 mM
TT) in a total volume of 10 l and incubated for 60 min  at 37 ◦C.
0 l of formamide loading dye was added, and the samples were
enatured at 80 ◦C for 10 min. The reaction products were resolved
n 20% denaturing polyacrylamide gels and visualized by autora-
iography as for the substrates. Puriﬁed core hNEIL3 enzyme was
uriﬁed as previously described and used as positive control [40].
.7. Total RNA isolation and Northern blot analysis
Total RNA was isolated from HaCaT cells using the TRIzol
eagent (Ambion, Applied Biosystems) according to manufacture’s
nstructions. mRNA was isolated from total RNA using the MicroP-
ly(A)Purist Kit (Ambion) and 8 g/lane was subjected to 1% (w/v)
enaturing agarose gel electrophoresis at 5 V/cm. RNA was trans-
erred to an Ambion BrightStar-Plus membrane by downward
ransfer from gel and crosslinked (at Preset energy setting) to
he membrane in a CL-1000 UV-Crosslinker (UVP, Upland, CA).
he Northern Max  kit (Ambion) was used in the blotting, pre-
ybridization/hybridization and washing steps of the membrane
s described by the manufacture. The probes were labeled using
mersham Rediprime II Random Prime labeling system (Amersham
iosciences) and easytide dCTP (-32P) (NEG513H, PerkinElmer).
he ﬁlter was exposed to a storage phosphor screen (GE Healthcare)
nd the hybridization signals were detected and quantiﬁed usingair 11 (2012) 401– 409 403
the  Typhoon 9410 and ImageQuant software (Molecular Dynam-
ics).
3. Results
3.1. Release from quiescence stimulates the expression of hNEIL3
As  hNEIL3 expression is conﬁned to proliferative tissues and
cells, we  examined the transcription level of hNEIL3 during cell
cycle progression by taking advantage of the Real-Time qRT-PCR
technique. Cells cultured in vitro can be arrested in the G0 phase
of the cell cycle, either by serum starvation or by contact inhibition
repressing pRB-phosphorylation by distinct mechanisms. Serum
deprivation results in a decrease of the positive regulators cyclin
D1 and cyclin D3, whereas contact inhibition acts via regulation
of the inhibitory proteins p16 and p27 [41]. We  combined these
conditions as this has been shown to synchronize human embry-
onal lung ﬁbroblasts with highest efﬁciency [41]. Release from the
G0 phase and cell cycle entry was achieved by culturing the cells
at subconﬂuence in complete serum containing medium. We  have
compared hNEIL3 transcription in human embryonic (HE) ﬁbrob-
lasts with hUNG2 and hFEN1, two  known replication associated
enzymes [42–48]. As seen in Fig. 1, hNEIL3 transcription was upreg-
ulated during cell cycle progression. Human NEIL3 transcription
was induced in early S phase, hUNG2 and hFEN1 in late G1 phase.
Human NEIL3 and hFEN1 transcription was sustained through G2/M
phase while hUNG2 transcription declined in late S phase. More-
over, hNEIL3 was  the most highly induced gene, reﬂecting the low
basal level in quiescent cells.
To address the question whether the transcriptional regulation
of hNEIL3 in HE cells was  cell lineage speciﬁc or a more general reg-
ulation pattern in proliferating cells, we investigated the hNEIL3
level in primary human fetal lung ﬁbroblasts (MRC-5), human
keratinocytes (HaCaT) and human breast tumor epithelial cells
(MCF-7). Conﬂuent and serum starved cells were released and fol-
lowed for 4 days until they once more reached conﬂuence. As seen
in Fig. 2, hNEIL3 transcription was induced in all the cell cultures,
albeit variations in the time of induction and level of expression
were observed in the different cell lines. These variations most
probably reﬂect the efﬁciency of synchronization, cell phase pro-
gression and the capacity to be contact inhibited. HE cells were
relatively synchronized for 32 h after G0 release, at later time points
they were more randomly distributed showing a reduced level at
day 2. The MCF-7 cells tended to grow as a two-layer which con-
ﬁrm that they are unable to be contact inhibited and may  reﬂect
the relatively high level of hNEIL3 at day 0. Overall, hNEIL3 was
highly expressed in cells that were in a proliferative state, at days
3–4 when reaching conﬂuence and cell cycle arrest the hNEIL3 level
dropped.
These ﬁndings prompted us to examine whether the amount
of hNEIL3 protein reﬂected changes in transcriptional level. We
could not detect hNEIL3 protein in Western blot experiments of
total protein extracts from unsynchronized HE or HaCaT cells (data
not show). However, a prominent band of around 70 kDa was
detected when total protein extracts from unsynchronized HE or
HaCaT were immunoprecipitated with NEIL3 antibody. This band
was absent in the control experiments that did not include NEIL3
antibody in the immunoprecipitation sample (Fig. 3A). The 70 kDa
band was  cut from the gel and subjected to MS-based sequencing.
Altogether, 4 different peptides identiﬁed corresponded to hNEIL3.
We next subjected the immunoprecipitated samples containing or
lacking hNEIL3 antibody to a standard DNA glycosylase activity
assay toward ssGH. As seen in Fig. 3B, activity toward ssGh was
detected in the lane in which hNEIL3 was immunoprecipitated and
absent in the sample lacking NEIL3 antibody. Next, Western blot
404 C.G. Neurauter et al. / DNA Rep
Fig. 1. Upregulation of hNEIL3 in quiescent HE ﬁbroblasts stimulated to proliferate.
HE  ﬁbroblasts were serum starved at conﬂuence and G0 released by replating 1:4 in
serum containing culture medium. Normalized hNEIL3, hUNG2 and hFEN1 relative
transcript levels (RQ) were measured during cell cycle progression upon G0 release
at indicated time points after release by qPCR. G0 cells used as the reference sample
for RQ calculation. Cell cycle distribution was  monitored using propidium iodide
staining followed by ﬂow cytometry after release from the block. The percentage
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starved HE cells with the kinase inhibitors SB203580 (p38a,b,b2f  cells in each cell cycle phase is presented in the table. Experiment was repeated
wice,  one representative experiment is displayed.
xperiments, as shown in Fig. 3C revealed that hNEIL3 levels, virtu-
lly undetected in arrested cells, showed a similar increase in HaCaT
ells during cell cycle progression. Finally, to measure whether
EIL3 activity followed the amount of hNEIL3 protein, DNA glyco-
ylase assays were carried out using immunoprecipitated hNEIL3
rom various time points after release from quiescence. As seen in
ig. 3D, DNA glycosylase activity mirrored hNEIL3 protein levels.air 11 (2012) 401– 409
3.2. Opposite pattern of hNEIL1 and hNEIL3 gene expression
Next, we  compared the relative transcript level of the three
hNEIL homologues in contact inhibited and serum starved syn-
chronized HE and HaCaT cells. Interestingly, opposite patterns of
regulation of hNEIL1 and hNEIL3 in quiescent cells were observed
(Fig. 4A and B). In contrast, for hNEIL2 transcription, phase inde-
pendent expression was  observed (Fig. 4A and B). Intriguingly, our
results showed a strong repression of hNEIL1 transcription upon G0
release. The repression was also observed for the serum starved,
contact inhibited MRC-5 cells (data not shown), this is in contrast
to the expression pattern in serum starved MRC-5 cells reported
by Mitra et al. [9]. Several hNEIL1 transcripts have previously been
detected in Northern blots [9,11,19]. As these cannot be distin-
guished by the primer pair used in the Real-Time qRT-PCR reactions
we performed Northern blotting of mRNA from HaCaT cells upon G0
release to identify the different transcripts (Fig. 4C). In our exper-
iments, the 4 kb and the 1.8 kb hNEIL1 transcripts along with the
smaller RNA specie observed by Mitra et al. were identiﬁed and
normalized to the ˇ-ACTIN levels (Fig. 4C). The 4 kb band is the
main transcript detected in human tissues, while the 1.8 kb band is
the so called completely processed product. At G0, an intense 4 kb
hNEIL1 transcript was  observed which decreased 50 times 27 h after
release and was  absent in unsynchronized cells. Both the 1.8 kb and
the smaller transcript also decreased signiﬁcantly (3–6 times) upon
release. In contrast, hNEIL3 transcription was induced in cycling
cells. The more prominent band in the unsynchronized cells could
reﬂect that the cells are in a higher proliferative state than cells
which are released from G0.
3.3. Identiﬁcation of E2F elements in the promoter region suggest
Rb  dependent regulation of the hNEIL3 gene
The majority of promoters of cell cycle-regulated genes are GC-
rich and TATA-less and with a high frequency of E2F binding sites
[37,49]. We  have used the MatInspector program to search for char-
acteristic promoter elements of cell cycle-regulated genes. Several
E2F, Sp1, CREB, NRF-1, NF-Y transcription factors and cell cycle-
dependent element (CDE)/cell cycle gene homology region (CHR)
cis-regulatory elements were predicted (Fig. 5). Several of the E2F,
Sp1 and the CDE/CHR binding elements were in close proximity to
the transcriptional initiation site.
3.4. Human NEIL3 induction upon cell cycle entry is mediated
through the MAP kinase signaling cascade
We have demonstrated a cell cycle-dependent regulation of
hNEIL3 and the putative E2F elements in the 5′UTR  suggested an
Rb dependent regulation. The transition of cells from G0/G1 to S is
regulated by cyclin D1/E and their cognate CDKs which phosphory-
lates and inactivates the retinoblastoma protein family [32,33,50].
The cyclin D1/E level is induced by mitogenic stimulation, involving
RTKs, MAP  kinases and activation of several families of transcrip-
tion factors [34–36]. In order to further elucidate the regulation
of hNEIL3 expression we  examined the dependence on one or sev-
eral of the MAP  kinase pathways upon mitogenic stimulation and
G1/S transition of quiescent cells. Four MAP  kinase pathways have
been identiﬁed [51,52]. These are the extracellular signal-regulated
kinase 1/2 (ERK1/2), c-Jun N-Terminal kinase (JNK), p38, and ERK5
cascades. Speciﬁc chemical inhibitors of the four MAP  kinase cas-
cades have been widely used in cell culture systems to study
the different pathways. We treated contact inhibited and seruminhibitor), SP600125 (JNK inhibitor), U0126 (MEK ERK1/2 inhibitor)
and N-acetyl cystein (NAC, a ROS inhibitor) followed by G0 release.
The antioxidant NAC is frequently used as an experimental tool to
C.G. Neurauter et al. / DNA Repair 11 (2012) 401– 409 405
Fig. 2. Human NEIL3 was  highly expressed in cells that were in a proliferative state. HE, MRC-5, HaCaT and MCF-7 cells were serum starved at conﬂuence and G0 released by
replating 1:4 in serum containing culture. Normalized hNEIL3 relative transcript level (RQ) was measured at indicated time points after release by qPCR, using G0 HE cells as
the  reference sample for RQ calculation Experiment was  repeated twice, one representative experiment is presented.
Fig. 3. Human NEIL3 protein levels and DNA glycosylase activity mirrored hNEIL3 expression proﬁle. Unsynchronized HaCaT cells were immunoprecipitated by NEIL3
antibody. (A) Western blot analysis of unsynchronized HaCaT cells that were immunoprecipitated with NEIL3 (+ NEIL3) or a control lacking NEIL3 antibody (− NEIL3).
Arrows indicate the 70 kDa band sequenced, The IgG heavy chain and non-speciﬁc binding proteins. (B) Immunoprecipitated samples were incubated with a 32P-labeled
single stranded Gh oligonucleotide in a standard DNA glycosylase activity assay. Substrate alone (Subs), puriﬁed core hNEIL3 (core-hNEIL3), immunoprecipitate without
NEIL3 antibody (IP − NEIL3) and immunprecipitate with NEIL3 antibody (IP + NEIL3). HaCaT cells were serum starved at conﬂuence and G0 released by replating 1:4 in serum
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hontaining culture. (C) Western blot analysis detecting endogenous immunopreci
uring cell cycle progression upon G0 release at indicated time points after release
ssess the involvement of ROS in various signal transduction path-
ays [53–56]. All inhibitors at the given concentrations, except for
he p38 inhibitor, inhibited proliferation totally. As seen in Fig. 6
NEIL3 induction was dependent on activated kinases, mostly by
he Ras dependent ERK–MAP kinase pathway. At 17 h after stimu-
ation the transcription was inhibited totally, and at 23 h there was
 50–60% inhibition. The JNK inhibitor had a minor effect on hNEIL3
ranscription while no signiﬁcant effect was observed by p38 or
OS inhibition. Human FEN1 showed a similar regulation pattern
s hNEIL3. In contrast, the p38 and JNK inhibitors mediated an
pregulation of the hUNG2 transcript level, while the ERK inhibitor
ppeared to delay the transcription. NAC had no signiﬁcant effect on
UNG2 transcription. The repression of hNEIL1 transcription at G1/Sd hNEIL3, and (D) DNA glycosylase activity on an ssGh substrate were measured
synchronized cells.
transition  was  not affected by any of the kinases or ROS  inhibitors
(data not shown).
4.  Discussion
Under our experimental conditions, our data established that
the three members of the Nei/Fpg family of DNA glycosylases,
hNEIL1, hNEIL2 and hNEIL3 were distinctly regulated during cell
cycle progression. Human NEIL3 was highly upregulated upon
release from quiescence. In contrast, hNEIL1 was repressed while
the expression of hNEIL2 was  unaffected. Synchronous cell popula-
tions can be obtained by several methods in order to study events
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Fig. 4. Human NEIL1 and NEIL3 were down- and up-regulated respectively upon release from quiescence. (A) HE ﬁbroblasts, and (B) HaCaT cells were serum starved at
conﬂuence and G0 released by replating 1:4 in serum containing culture medium. Normalized hNEIL1, hNEIL2 and hNEIL3 relative transcript level (RQ) were measured at
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RNA  was  loaded on the gel and the Ambion RNA Millennium Marker was  used as
ccurring through the cell cycle. Several methods, including con-
act inhibition, serum deprivation, thymidine blocks or drugs are
idely used to synchronize cells [41,57]. In this study we chose
o synchronize cells by both contact inhibition and serum depri-
ation as these conditions in combination have shown to give
dditive anti-proliferative effect and in addition contact inhibi-
ion play the fundamental role in proliferation control in vivo (i.e.
ound-healing [41]).
The  expression of hNEIL3 was regulated both at the transcrip-
ional and protein level as the cells entered the cell cycle from
uiescence, showing an induction in early S phase which pro-
onged through G2/M as for hFEN1. The onset of induction was
agging approximately 4 h compared to hUNG2 and hFEN1 but the
nduction level was signiﬁcantly higher than for hUNG2 in partic-
lar, reﬂecting a very low basal level of hNEIL3 in quiescent cells
nd non-proliferating tissue. Moreover, hNEIL3 has been picked in
everal genome wide screens that identify genes that are cell cycle-
egulated, with highest expression in the G2 phase [58,59]. The
-500                     -400                         -300                        -200                        -100    
ig. 5. Analysis of the −500 to +300 base pair region of human NEIL3 revealed the presen
romoter elements that are involved in cell cycle regulation. The transcription initiation RQ calculation Experiment was repeated twice, one representative experiment is
CTIN for normalization at the indicated time points. U: unsynchronized cells. 8 g
 size standard.
hNEIL3  expression seems not to be conﬁned to any cell lineage, but
the onset and level of induction upon G0 release varies. Efﬁciency of
synchronization, cell phase progression or the capacity to be con-
tact inhibited may  affect the expression pattern of hNEIL3 in the
different lineages. Loss of regulation at the G1/S transition appears
to be a common event among virtually all types of human tumors
[60,61]. This was observed with the MCF-7 cells from breast tumor
which tended to grow as a two-layer not being contact inhibited.
In addition, lineage speciﬁc expression of distinct transcription fac-
tors could also have an inﬂuence on the transcript level of hNEIL3
in the various lineages.
Human  NEIL3 being a cell cycle-regulated gene was supported
by the analysis of its 5′ upstream promoter region which revealed
several features that characterize such genes. Of  particular interest
are the E2F binding sequences, the cell cycle-dependent element
(CDE) and the cell cycle genes homology region (CHR) located prox-
imal to the transcription initiation site. Interestingly, in genome
wide studies using chip-on-chip to identify E2F4 and p130 (Rb
NRF-1NFYCDECHRSp1E2FCREB
                      +1                          +100     +200                         +30 0
ce of several putative E2F sites. The MatInspector program was used to search for
site is shown by an arrow.
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cp38a,b,b2 inhibitor, 10 M),  SP600125 (JNK inhibitor, 20 M),  U0126 (MEK inhib
ormalized hNEIL3, hUNG2 and hFEN1 relative transcript level (RQ) were measured
Q  calculation. Experiment was repeated twice, one representative experiment is p
ocket protein) targets for transcriptional regulation of growth
rrest the hNEIL3 and hFEN1 genes were picked up [31,62,63].
oreover, in the study by DeCaprio and co-workers [31], hNEIL3
nd hFEN1 were identiﬁed as genes whose promoter was  strongly
ound by the DREAM complex in quiescent cells, while hUNG2 was
ound by a different complex.
Rb pocket protein inactivation by phosphorylation at the G1/S
ransition of cells is a consequence of a cascade of phosphorylation
vents upon mitogenic stimulation involving RTKs [34–36,51,52].
e have demonstrated that the induction of hNEIL3 transcription
hen cells entered the cell cycle was to a certain extent dependent
n the activation of the Ras dependent ERK–MAP kinase pathway in
articular. Human FEN1 and hUNG2 transcription were also affected
y kinase inhibitors in which the ERK–MAP kinase pathway was the
ost important for induction. In the case of hUNG2, the activation
f p38 and JNK kinases seemed to mediate repression. To get a more
etailed picture of the signaling pathways involved, several other
nhibitors and combination of inhibitors could have been used.
oreover, the use of speciﬁc mitogenic factors as a substitute for
erum stimulation could also elucidate this question. Regardless,
e present strong evidence supporting an Rb associated regulation
f hNEIL3 expression in mitogen stimulated cells.
In  contrast to hNEIL3, hNEIL1 transcription was strongly
epressed upon G0 release in contact inhibited and serum starved
onditions. Four hNEIL1 transcripts have been described in North-
rn blot experiments: a weak 1.8 kb transcript corresponding to the
ully processed hNEIL1 together with two highly expressed larger
ranscripts, claimed to be unprocessed hNEIL1, of about 4 and 8 kb
9,11,19]. The fourth transcript is a smaller transcript identiﬁed in
he MRC-5 cell line. Northern blot analysis revealed that the repres-
ion of hNEIL1 in HaCaT cells upon release from quiescence was
ainly due to downregulation of the 4 kb transcript but also a sig-
iﬁcant repression of the smaller transcripts. Interestingly, the 4 kb
NEIL1 transcript was not detected in subconﬂuent serum starved
RC-5 cells [9]. We  ascribe the different results to the conditions
sed in the experiments. Mitra and colleagues synchronized the
ells by serum starvation at subconﬂuence and by using identical
onditions with MRC5 cells we did not see the same high level of
NEIL1 transcription at G0 nor did it repress hNEIL3 and hUNG2 tran-
cription as efﬁciently as in combination with contact inhibition
data not shown). Thus, this 4 kb hNEIL1 transcript appears to be
peciﬁc in contact inhibited and contact inhibited/serum deprived
onditions. It is reported that both serum deprivation and contact20 M)  and N-acetyl cystein (NAC, ROS inhibitor, 10 mM).  NT: non-treated cells.
icated time points after release by qPCR, using G0 cells as the reference sample for
ted.
inhibition  lead to signiﬁcant and distinct changes in gene expres-
sion and apparently hNEIL1 transcription was  differently regulated
when cells were interacting [64]. The drastic repression of hNEIL1
transcription upon cell cycle entry was not dependent on the mito-
gen activated kinase pathways (data not shown).
Since all NEIL enzymes process DNA base lesions in single
stranded DNA, a function during replication or transcription when
partly unwound regions of DNA are exposed has been suggested.
hNEIL2 expression is independent of the cell cycle stage and
recently a role for hNEIL2 in repairing oxidized bases in the tran-
scribed genes of mammalian cells has been published [10,65]. The
results showing high expression of all the hNEIL1 transcripts in G0
arrested cells imply that the enzyme could have a function in quies-
cent contact inhibited cells and organs in addition to the proposed
replication associated repair of oxidative lesions [21–25]. We  could
not observe the S-phase speciﬁc expression of hNEIL1 using the
Real-Time qRT-PCR technique as the fully processed 1.8 kb tran-
script cannot be distinguished from the other larger transcripts.
Hence, we are not questioning the replication associated repair
of hNEIL1. Still, an intriguing question is why  the most abundant
mRNA transcript in contact inhibited and in human tissue in gen-
eral is the 4 kb specie referred to as unprocessed hNEIL1. A more in
depth study of hNEIL1 regulation at the transcriptional and protein
level in cells and organs would be elucidatory. Pertinent to this,
RNA editing of hNEIL1 was recently demonstrated to change the
substrate speciﬁcity of the enzyme [66].
Finally, NEIL3 has been the elusive enzyme of the three NEIL
homologues. In this paper we have shown for the ﬁrst time that
endogenous hNEIL3 has DNA glycosylase activity. As it has been
very difﬁcult to purify the full length recombinant enzyme, we have
shown that by synchronizing cells it is possible to immunoprecip-
itate enzymatically active hNEIL3 which can be used to conﬁrm
results obtained from recombinant NEIL3 enzymes. The expression
pattern of hNEIL3 could indicate that hNEIL3 is mainly involved
in replication associated repair. A predicted non-canonical PCNA
motif [67] and our previously reported co-localization of hNEIL3
with RPA [11] support this hypothesis.
In conclusion, the hNEIL3 glycosylase expressed in highly pro-
liferative cells was  found to be cell cycle-dependent and induced
when cells enter the S phase by mitogenic stimulation. The induc-
tion was  to a certain extent under the control of the Ras dependent
ERK–MAP kinase pathway. We  suggest that the hNEIL3 repression
in G0 arrested cells could be mediated by E2F4 binding through
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